Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Change in Account Payables (2016)

Historic Change in Account Payables for BioCorRx (BICX) over the last 8 years, with Q4 2016 value amounting to $328890.0.

  • BioCorRx's Change in Account Payables rose 26108.03% to $328890.0 in Q4 2016 from the same period last year, while for Dec 2016 it was -$42740.0, marking a year-over-year decrease of 10889.12%. This contributed to the annual value of -$42740.0 for FY2016, which is 10889.12% down from last year.
  • Latest data reveals that BioCorRx reported Change in Account Payables of $328890.0 as of Q4 2016, which was up 26108.03% from -$126365.0 recorded in Q3 2016.
  • In the past 5 years, BioCorRx's Change in Account Payables ranged from a high of $328890.0 in Q4 2016 and a low of -$250738.0 during Q2 2016
  • Moreover, its 5-year median value for Change in Account Payables was $65519.0 (2012), whereas its average is $47209.6.
  • The largest annual percentage gain for BioCorRx's Change in Account Payables in the last 5 years was 44280.07% (2012), contrasted with its biggest fall of 98919.51% (2012).
  • Over the past 5 years, BioCorRx's Change in Account Payables (Quarter) stood at $44323.0 in 2012, then skyrocketed by 191.1% to $129026.0 in 2013, then rose by 15.44% to $148942.0 in 2014, then tumbled by 38.85% to $91085.0 in 2015, then surged by 261.08% to $328890.0 in 2016.
  • Its last three reported values are $328890.0 in Q4 2016, -$126365.0 for Q3 2016, and -$250738.0 during Q2 2016.